Details
Tyler Golato is the Chief Scientist of Molecule, an open-source protocol for drug development. Previously, he worked at the National Institute of Aging Research (NIH/NIA/IRP) under the guidance of Dr. David M. Wilson III and Dr. Vilhelm Bohr, focusing on repairing endogenous DNA damage, especially in the context of aging. He also worked in the Robert Fine laboratory at Columbia University, researching the mechanisms of chemotherapy resistance in pancreatic cancer and developing novel therapeutic strategies for various types of cancer.
Work Experience
Relevance Person
Liesl Eichholz
Liesl Eichholz is the Co-Founder & CEO at Essential. She presively was the Head of Growth at Fuel Labs, Growth Strategist at Glassnode.
Paul Kohlhaas
Paul Kohlhaas is an entrepreneur and economist with a passion for open source utility networks. A profound passion for pharmaceutical innovation led him to found Molecule, a networked marketplace that enables the distributed R&D and funding of new chemical intellectual property. His research centers around the use of token engineering and autonomous market design to design novel incentive and legal structures that drive open source collaboration. He previously graduated in economics and politics from the University of St. Gallen, co-founded Linum Labs, a blockchain architecture studio and worked 1.5 years at ConsenSys, uPort, pioneering early real-world implementations in digital identity.